INC updates on plans to close former Kendle office
INC Research says the closure of former Kendle office in Connecticut will better balance resources and that – where possible – staff will be reassigned.
Archives for March 28, 2012
'Regulators: Get to the point', say experts at DIA Euromeeting
“Less bureaucracy and more research” was the Danish Minister of science and innovation’s message to regulators at this week's DIA Euromeeting.
Teva to sell Quebec plant and transfer 150 staff to US CMO
Teva is to sell its Quebec, Canada manufacturing facility and transfer 150 employees to US CMO Halo Pharmaceuticals.
Cetero eyes fast sale to private equity as FDA agreement nears
Cetero says it could have new private equity owners in 90 days and an agreed path forward with the FDA in weeks.
Longer punishments are poor fake drug deterrents; academic
An academic has questioned the wisdom of longer maximum penalties for counterfeiters at a House meeting to discuss sentencing.
update
BASF unveils R&D realignment plan, citing drug excipients as important
BASF has announced plans to restructure its R&D operations, citing solubility enhancing excipients as an opportunity for growth.
News from AMRI, AIT Laboratories, and Chemgen – People on the move
Outsourcing-Pharma presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from AMRI, AIT Laboratories, and Chemgen.
Warnex delays results and receives debenture default notice
Laboratory services firm Warnex has put back the release of its full year results and received a formal notice of default from the holder of its outstanding debentures.